Get the Stockscreener App
14.21
1.36%
0.19
Edgewise Therapeutics Inc stock is traded at $14.21, with a volume of 1.01M.
It is up +1.36% in the last 24 hours and down -4.18% over the past month.
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases. The company's product candidates are Sevasemten and EDG-7500. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company is currently studying Sevasemten in Phase 2 trials, which are being held in the U.S. and Israel and in certain countries in Europe and Australasia.
See More
Previous Close:
$14.02
Open:
$14.05
24h Volume:
1.01M
Relative Volume:
0.59
Market Cap:
$1.49B
Revenue:
-
Net Income/Loss:
$-115.88M
P/E Ratio:
-9.1867
EPS:
-1.5468
Net Cash Flow:
$-104.72M
1W Performance:
-3.86%
1M Performance:
-4.18%
6M Performance:
-55.87%
1Y Performance:
-17.91%
1-Day Range:
$13.63
$14.31
1-Week Range:
$13.63
$15.34
52-Week Range:
$10.60
$38.12
Edgewise Therapeutics Inc Stock (EWTX) Company Profile
Name
Edgewise Therapeutics Inc
Sector
Industry
Phone
720-262-7002
Address
1715 38TH ST, BOULDER
Compare EWTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EWTX
Edgewise Therapeutics Inc
|
14.21 | 1.55B | 0 | -115.88M | -104.72M | -1.5468 |
|
ONC
Beigene Ltd Adr
|
241.43 | 27.03B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.00 | 112.64B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.335 | 40.86M | 0 | 0 | 0 | 0.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.34 | 64.17B | 14.09B | 4.50B | 2.96B | 39.28 |
|
VRNA
Verona Pharma Plc Adr
|
75.06 | 6.07B | 0 | -153.72M | -103.81M | -2.00 |
Edgewise Therapeutics Inc Stock (EWTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-30-25 | Initiated | Guggenheim | Buy |
| Apr-02-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-07-25 | Initiated | Scotiabank | Sector Outperform |
| Jan-22-25 | Initiated | Stifel | Hold |
| Nov-22-24 | Initiated | Evercore ISI | Outperform |
| Mar-07-24 | Initiated | Piper Sandler | Overweight |
| May-01-23 | Initiated | Truist | Buy |
| Aug-25-22 | Downgrade | Goldman | Neutral → Sell |
| Apr-13-22 | Initiated | RBC Capital Mkts | Outperform |
| Jan-28-22 | Initiated | Goldman | Neutral |
View All
Edgewise Therapeutics Inc Stock (EWTX) Latest News
Edgewise Therapeutics’ SWOT analysis: promising rare disease pipeline faces challenges - Investing.com Nigeria
BNP Paribas Financial Markets Makes New $883,000 Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Purchased by Woodline Partners LP - MarketBeat
Frazier Life Sciences Management L.P. Reduces Stock Holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Polar Asset Management Partners Inc. Trims Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Point72 Asset Management L.P. Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Deutsche Bank AG Has $7.37 Million Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
How to Take Advantage of moves in (EWTX) - news.stocktradersdaily.com
Tang Capital Management LLC Buys Shares of 300,000 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Soleus Capital Management L.P. Makes New Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Northern Trust Corp Acquires 35,426 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Balyasny Asset Management L.P. Buys Shares of 23,364 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
All You Need to Know About Edgewise Therapeutics (EWTX) Rating Upgrade to Buy - MSN
Ensign Peak Advisors Inc Acquires New Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Brokerages Set Edgewise Therapeutics, Inc. (NASDAQ:EWTX) PT at $40.22 - MarketBeat
Edgewise Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference on May 20, 2025 - PR Newswire
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) is MPM Bioimpact LLC's 3rd Largest Position - MarketBeat
Paradigm Biocapital Advisors LP Grows Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Parkman Healthcare Partners LLC Sells 275,897 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Janus Henderson Group PLC Purchases 425,421 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
D. E. Shaw & Co. Inc. Purchases 231,023 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
J. Goldman & Co LP Increases Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Research Analysts Offer Predictions for EWTX FY2029 Earnings - MarketBeat
Granahan Investment Management LLC Sells 211,892 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Northern Trust Corp Boosts Stock Position in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - Defense World
Cubist Systematic Strategies LLC Makes New $5.86 Million Investment in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Does Edgewise Therapeutics (EWTX) Have the Potential to Rally 174.68% as Wall Street Analysts Expect? - Yahoo Finance
Muscle Disease Leader Edgewise Therapeutics Takes Stage at RBC Healthcare Conference - Stock Titan
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Sold by DAFNA Capital Management LLC - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Shares Acquired by Algert Global LLC - MarketBeat
Deerfield Management Company L.P. Series C Buys 297,503 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Driehaus Capital Management LLC Sells 459,633 Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Stock Holdings Trimmed by Deep Track Capital LP - MarketBeat
Braidwell LP Has $62.27 Million Stake in Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Bamco Inc. NY Buys Shares of 60,000 Edgewise Therapeutics, Inc. (NASDAQ:EWTX) - MarketBeat
Learn to Evaluate (EWTX) using the Charts - news.stocktradersdaily.com
Edgewise Therapeutics Inc Stock (EWTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
17.27%
1.06%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):